Head-to-Head Comparison of 68Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients | Journal of Nuclear Medicine
Chemosensors | Free Full-Text | Novel Prostate Cancer Biomarkers: Aetiology, Clinical Performance and Sensing Applications
NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016 in: Journal of the National Comprehensive Cancer Network Volume 14 Issue 5 (2016)
Frontiers | Urine Exosomal AMACR Is a Novel Biomarker for Prostate Cancer Detection at Initial Biopsy
Diagnostic performance of 18F-PSMA-1007 PET/CT in biochemically relapsed patients with prostate cancer with PSA levels ≤ 2.0 ng/ml | Prostate Cancer and Prostatic Diseases
Frontiers | A compendium of Androgen Receptor Variant 7 target genes and their role in Castration Resistant Prostate Cancer
MAJOR LEAGUE BASEBALL AND PROSTATE CANCER FOUNDATION PARTNER ON 26TH ANNUAL HOME RUN CHALLENGE AND TOUR
Prostate Cancer Treatment (PDQ®) - NCI
PCA3 Test Now Offered at Dr. Samadi's Prostate Cancer Center
La classification TNM des cancers de la prostate
A Nationwide Analysis of Risk of Prostate Cancer Diagnosis and Mortality following an Initial Negative Transrectal Ultrasound Biopsy with Long-Term Followup | Journal of Urology
Cancer de la prostate : l'autotest de nouveau autorisé - AlloDocteurs
Elevated PSA Doesn't Always Mean Prostate Cancer
There is current over-treatment of prostate cancer in France - Inserm Newsroom
Using PSMA imaging for prognostication in localized and advanced prostate cancer | Nature Reviews Urology
Cancers | Free Full-Text | A Novel Urine Exosomal lncRNA Assay to Improve the Detection of Prostate Cancer at Initial Biopsy: A Retrospective Multicenter Diagnostic Feasibility Study
Cancers | Free Full-Text | Derivation and Application of Molecular Signatures to Prostate Cancer: Opportunities and Challenges
Beyond PSA: The Next Generation of Prostate Cancer Biomarkers | Science Translational Medicine
IJMS | Free Full-Text | Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers
Screening and prostate cancer | PPT
Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men | Prostate Cancer and Prostatic Diseases
A 59-year-old male with newly diagnosed prostate cancer (GS: 4+4, ISUP... | Download Scientific Diagram
Profiling the proteoforms of urinary prostate-specific antigen by capillary electrophoresis – mass spectrometry - ScienceDirect
